Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Cancers|December 11, 2022
Trop-2 as a Therapeutic Target in Breast CancerElizabeth Sakach, Ruth Sacks, Kevin KalinskyClinical Breast Cancer|October 11, 2021
Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted TherapiesElizabeth Sakach, Ruth O'Regan, Jane Meisel, et al.Current Treatment Options in Oncology|June 14, 2023
CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed?Elizabeth Sakach, Merve Keskinkilic, Sarah Wood, et al.Drugs|July 28, 2026
Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast CancerLan Lei, Madison Canning, Elizabeth Sakach, et al.Clinical Colorectal Cancer|March 20, 2021
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective ReviewEvan Bryson, Elizabeth Sakach, Urvi Patel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2023
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN TrialKevin Kalinsky, Melissa K Accordino, Codruta Chiuzan, et al.Pageof 1